Filter Results
:
(1,001)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
Show Results For
-
All HBS Web
(1,001)
- People (4)
- News (249)
- Research (603)
- Events (7)
- Multimedia (24)
- Faculty Publications (389)
- February 2022 (Revised July 2022)
- Supplement
InstaDeep: AI Innovation Born in Africa (B)
By: Shikhar Ghosh and Esel Çekin
Karim Beguir and Zohra Slim were the co-founders of InstaDeep, a deep tech startup focusing on artificial intelligence (AI) solutions. Instadeep was one of the few companies globally that were partnering with DeepMind, an AI subsidiary of Google [Alphabet Inc.]....
View Details
Keywords:
AI;
Artificial Intelligence;
Entrepreneurship;
Operations;
Business Subsidiaries;
Brands and Branding;
Innovation and Invention;
Growth and Development Strategy;
AI and Machine Learning;
Technology Industry;
Africa
Ghosh, Shikhar, and Esel Çekin. "InstaDeep: AI Innovation Born in Africa (B)." Harvard Business School Supplement 822-105, February 2022. (Revised July 2022.)
- Article
Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials
By: Caroline Marra, William J. Gordon and Ariel Dora Stern
Objectives: In an effort to mitigate COVID-19 related challenges for clinical research, the U.S. Food and Drug Administration (FDA) issued new guidance for the conduct of ‘virtual’ clinical trials in late March 2020. This study documents trends in the use of...
View Details
Keywords:
Connected Digital Products;
Telehealth;
Remote Monitoring;
Health Testing and Trials;
Research;
Governing Rules, Regulations, and Reforms;
Information Technology
Marra, Caroline, William J. Gordon, and Ariel Dora Stern. "Use of Connected Digital Products in Clinical Research Following the COVID-19 Pandemic: A Comprehensive Analysis of Clinical Trials." BMJ Open 11, no. 6 (2021).
- 2014
- Working Paper
Non-Adherence in Health Care: A Positive and Normative Analysis
By: Mark Egan and Tomas J. Philipson
Non-adherence in health care results when a patient does not initiate or continue care that a provider has recommended. Previous research identifies non-adherence as a major source of waste in US health care, totaling approximately 2.3% of GDP, and have proposed a...
View Details
Egan, Mark, and Tomas J. Philipson. "Non-Adherence in Health Care: A Positive and Normative Analysis." NBER Working Paper Series, No. 20330, July 2014. (Previously titled, "Health Care Adherence and Personalized Medicine.")
- Research Summary
Overview
ECONOMICS OF THE ADVERTISING AND MARKETING SERVICEC INDUSTRY
Professor Silk’s recent research has been focused on the economics of the advertising and marketing services industry. He has conducted econometric studies of the effects of scale and scope on the... View Details
- 15 Jul 2013
- Research & Ideas
Five Imperatives for Improving Health Care
innovation efforts traditionally have focused on new products such as drugs and devices, survey respondents ranked process improvements in care delivery as the most promising opportunity for improving the cost and quality of health care....
View Details
- Web
Sample Student Projects - Institute For Strategy And Competitiveness
Services (2008) Iceland Iceland Financial Services (2008) India The Antiretroviral Drug Cluster in India (2017) Andhra Pradesh Pharmaceutical Cluster (2013) Tamil Nadu (India) Automotive Cluster (2012) Tirupur (India) Knitwear (2011)...
View Details
- 21 Sep 2022
- Research & Ideas
You Don’t Have to Quit Your Job to Find More Meaning in Life
overpriced drugs (moral condition) or drove patients into debt by increasing prices (immoral condition). Only 19 percent of participants said Ariana’s life was meaningful when she drove patients into debt by increasing prices. By...
View Details
Keywords:
by Shalene Gupta
- Web
HBS Alumna Fighting Cancer with a Novel Cell Therapy - MBA
Blog Blog MBA Voices Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Career and Professional Development Staff Author HBS Community Author HBS Faculty Author MBA Admissions Author MBA Students Topics Topics 1st Year (RC) 2+2 Program 2nd Year...
View Details
- 26 Aug 2024
- Blog Post
HBS Lingo 101
Program. Graduates earn two degrees in two years and are prepared to grow transformative organizations that will advance new drug discoveries or therapeutics. HIVES: Classrooms in Batten Hall designed with FIELD courses in mind to...
View Details
- Web
Student Research - Doctoral
2024 Article Academy of Management Best Paper Proceedings Effects of a Real-Time Information-Based Intervention on Physician Prescribing Behavior By: Olivia Zhao and Anna D Sinaiko High out-of-pocket (OOP) prices for prescription drugs...
View Details
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a...
View Details
- Web
Faculty & Advisors - MBA
Chairman of Blink Health LLC, an e-commerce platform providing access to prescription drugs for all Americans. Bill is also the lead independent director of Minerva Neuroscience and a director of Optinose, Inc. Previously, Bill was a...
View Details
- Web
Fostering Innovation in Life Sciences - Health Care
the vibrant entrepreneurial community at Harvard. GETTING LIFE-SAVING DRUGS TO MARKET is a research focus for Professor Amitabh Chandra . He examines the unique effects that economics and market factors have on the development of...
View Details
- Web
Curriculum - Business & Environment
development, illegal drugs, rent control, housing, drug pricing, racial references, corporate political action, social media, sea level rise, employment of people with disabilities, and the like. For example, instead of discussing general...
View Details
- 30 May 2024
- Research & Ideas
Racial Bias Might Be Infecting Patient Portals. Can AI Help?
differences in response to different types of customers,” Stern says. “To the extent those exist, that means you’re not serving a certain group of customers, and you’re potentially leaving money on the table.” You Might Also Like: The FDA’s Speedy View Details
- Web
Winners & Runners-Up | New Venture Competition
Business Track Winner Redefining precision agriculture through AI-powered, genetic insights. Sanso Narek Dshkhunyan (MBA 2024) Daniel Erdosy Business Track Runner-Up We help drug manufacturers produce life-saving biologics more...
View Details
- Fast Answer
Patent search: license agreement
a company patent license agreements. You may begin with SEC EDGAR, or LSEG Workspace. For information about drug out-licensing, please use Cortellis You may also find aggregated View Details
- January 2008 (Revised January 2008)
- Case
Two Brattle Center: A Mental-Health Clinic in Search of a Viable Operating Model
By: Robert G. Eccles
Two Brattle Center (TBC) is a struggling for-profit private mental health clinic based in Harvard Square. Its founder, Dr. Joan Wheelis, is a nationally recognized practicing psychiatrist who has developed outpatient treatment programs based on Dialectical Behavior...
View Details
Keywords:
Business Model;
For-Profit Firms;
Decision Choices and Conditions;
Financial Strategy;
Health Care and Treatment;
Health Disorders;
Medical Specialties;
Nonprofit Organizations;
Emotions;
Health Industry;
United States
Eccles, Robert G. "Two Brattle Center: A Mental-Health Clinic in Search of a Viable Operating Model." Harvard Business School Case 408-103, January 2008. (Revised January 2008.)
- Web
Pagliuca Harvard Life Lab | About
biotech and other life-sciences ventures that require wet lab facilities to test chemicals, drugs or other materials. It provides an experiential, educational environment where students and faculty can put classroom ideas directly into...
View Details
- Web
Information Technology - Institute For Strategy And Competitiveness
concordance, decision support, and follow-up of clinical alerts (such as labs, drug interactions, allergies, and others) 6. Makes it easy to extract and report information Ability to seamlessly measure and capture patient-specific...
View Details